GlassScriptPhysician profile
Leslie Jansa
NPI 1326324757
$44,517.01
in general payments reported to CMS, 2019-2025
27 companies · $45.74 in 2025
The $45.74 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $853 · 2022: $25K · 2023: $14K · 2024: $4,438 · 2025: $45.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $3,572 · Food and Beverage: $3,141 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,143.75 |
| Travel and Lodging | $3,572.16 |
| Food and Beverage | $3,141.27 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $22,643.38 | 2022 | |
| Abbvie INC. | $17,999.23 | 2021-2025 | |
| Janssen Biotech, INC. | $700.90 | 2021-2024 | Tremfya |
| Incyte Corporation | $348.10 | 2021-2024 | Opzelura |
| Galderma Laboratories, L.P. | $327.77 | 2021-2024 | Aklief, Epsolay, Oracea |
| Novartis Pharmaceuticals Corporation | $245.87 | 2021-2023 | |
| Pfizer INC. | $212.97 | 2021-2023 | |
| Amgen INC. | $189.24 | 2021-2024 | Otezla |
| Lilly USA, LLC | $186.51 | 2021-2024 | Olumiant, Taltz |
| Sun Pharmaceutical Industries INC. | $184.73 | 2021-2023 | Absorica Ld, Winlevi |
| Ucb, INC. | $184.38 | 2021-2024 | Bimzelx |
| Genzyme Corporation | $166.42 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $152.40 | 2022-2024 | Sotyktu |
| Janssen Pharmaceuticals, INC | $144.30 | 2021-2023 | Xarelto |
| Almirall LLC | $120.67 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $108.65 | 2022-2024 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $103.20 | 2021-2024 | Cabtreo, Jublia, Duobrii |
| Regeneron Healthcare Solutions, INC. | $100.00 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $90.02 | 2024 | |
| Dermavant Sciences, INC. | $70.24 | 2023-2024 | Vtama |
| Journey Medical Corporation | $62.29 | 2022-2023 | |
| Abbott Laboratories | $48.74 | 2023-2024 | Cardiomems |
| Biofrontera INC. | $41.60 | 2021-2022 | |
| Mentor Worldwide LLC | $23.10 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Medtronic, INC. | $22.98 | 2021 | |
| Epi Health, LLC | $20.10 | 2022 | |
| Novo Nordisk INC | $19.22 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Jansa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.